A recent outbreak of Chikungunya virus (CHIKV) in Italy has raised alarms across Europe, urging travellers to take extra precautions. Approximately 110 locally acquired chikungunya cases have been reported in Emilia-Romagna and Veneto regions in Italy since July 2025. Chikungunya cases have not been reported in Italy since 2017.  

While Chikungunya is typically found in tropical and subtropical regions, the spread of the Aedes mosquito responsible for transmission – active from sunrise to sunset – has now extended into Italy. This has led to heightened concerns, particularly as the region remains a popular destination for UK travellers. 

Chikungunya is a viral infection that can cause sudden high fever, debilitating joint and muscle pain, headaches, skin rashes, and photophobia. While most people recover in 1–2 weeks, up to 12% of people can suffer from joint pain that can persist for months to years, and in rare cases, the virus may lead to more serious complications. 

At Fleet Street Clinic, we now offer two Chikungunya vaccines for eligible travellers: 

IXCHIQ: A live attenuated vaccine suitable for immunocompetent individuals aged 18–59 years. 

Vimkunya: A virus-like particle vaccine using recombinant DNA technology available for individuals aged 12 years and older 

There is no specific antiviral treatment for Chikungunya, therefore making prevention through vaccination and mosquito bite avoidance essential. Travellers to affected areas should consult a healthcare professional for up-to-date advice and vaccine suitability. 

Estimate the savings you could make with a workplace flu vaccination programme with our flu calculator: https://flujabs.org/flu-calculator/

References https://travelhealthpro.org.uk/disease/31/chikungunya 

https://www.travax.nhs.uk/news/news-record-page?newsid=24899  

https://www.travax.com/account/login/index?ReturnUrl=%2Flibrary%2Fchikungunya 

September is Alzheimer’s Awareness Month, highlighting the importance of brain health and dementia prevention. In the UK, over 900,000 people live with dementia (Alzheimer’s Society, 2024), with Alzheimer’s disease being the most common type. Whilst there is no cure, taking proactive steps can reduce your risk or delay onset.

There are several proven ways to help protect your brain:
– Stay physically active as exercise improves circulation and supports brain function.
– Eat a balanced diet by prioritising lean protein, fruits, vegetables, whole grains and healthy fats.
– Keep mentally and socially engaged like reading, puzzles and social interaction stimulate your brain.
– Manage cardiovascular risk factors as high blood pressure, cholesterol and diabetes can increase dementia risk.
– Prioritise sleep and stress management as poor sleep and chronic stress negatively impact brain health.

Recent observational studies (npj vaccines, 2025) suggest that certain adult vaccines may also support long-term brain health. Research on the shingles vaccine (Shingrix) and the RSV vaccine (Arexvy) both containing the AS01 adjuvant shows a potential link to reduced dementia risk. 

• Adults who received Shingrix had an 18% lower dementia diagnosis rate compared to those who only received the flu vaccine. 

• Adults who received Arexvy had a 29% lower dementia diagnosis rate. 

• Receiving both vaccines was associated with a 37% reduction in dementia risk, suggesting a potential additive effect. 

These findings highlight an exciting area of research and the importance of keeping vaccinations up to date.

Our clinic can help you to:
– Review your vaccination history for shingles and RSV vaccines
– Book same day appointments
– Provide personalised advice for preventive health strategies

Alzheimer’s Awareness Month is a reminder to take proactive steps for your brain health. Keeping up to date with vaccines like Shingrix (NHS, 2023), alongside lifestyle measures, can be a simple yet impactful way to protect your future. 

Book your appointment today to review your vaccinations and receive expert advice. (link booking system) 

Read The Times article on vaccines and dementia (https://www.thetimes.co.uk/article/shingles-vaccine-dementia-risk-study-2025) 

Sources:
Alzheimer’s Society, 2024 – https://www.alzheimers.org.uk/about-us/policy-and-influencing/dementia-scale-impact-numbers
npj vaccines, 2025 – https://www.nature.com/articles/s41541-025-01172-3
NHS, 2023 – https://www.nhs.uk/vaccinations/shingles-vaccine/
 

• High fever
• Severe joint and muscle pain
• Fatigue
• Rash
• Headache